GHP Q2 2018

GHP / Q2 2018 9 Creating a World of Good Health, Happiness and Hope g Company: Intas Pharmaceuticals Website: www.intaspharma.com clear vision for Intas to become an active competitor in B2B sales throughout Europe. “Here at Intas, our vision is to become one of the most active players in the Out-licensing & B2B of pharmaceuticals in Europe. With this acquisition, we add a basket of new products to our already broad portfolio and reinforce our strong positioning in the out-licensing business. On top of that, we will also enlarge our platform of partnerships throughout the European market.” Ultimately, this transaction has led to a wealth of optimism throughout Intas, as it looks to capitalise and build on this announcement. As such, the future looks very bright indeed for the team at Intas.